Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.320 |
None |
1.000 |
5 |
|
2001 |
2019 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
5 |
6
|
2009 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2018 |
Hyperalgesia, Thermal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
154
|
|
0.310 |
None |
1.000 |
4 |
|
2001 |
2019 |
Mechanical Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
408
|
4
|
0.310 |
None |
1.000 |
4 |
|
2001 |
2019 |
Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
3 |
|
2001 |
2010 |
Hyperalgesia, Primary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
3 |
|
2001 |
2010 |
Hyperalgesia, Secondary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
88
|
|
0.300 |
None |
1.000 |
3 |
|
2001 |
2010 |
Tactile Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
114
|
|
0.300 |
None |
1.000 |
3 |
|
2001 |
2010 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2019 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
2 |
1
|
2019 |
2019 |
Corpuscular Hemoglobin Concentration Mean
|
phenotype |
|
Laboratory or Test Result
|
401
|
4389
|
0.100 |
None |
1.000 |
2 |
32
|
2012 |
2013 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Fibrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
184
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cardiomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
267
|
11
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
207
|
19
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Triiodothyronine measurement
|
phenotype |
|
Laboratory Procedure
|
6
|
12
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |